BG104689A - Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system - Google Patents
Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous systemInfo
- Publication number
- BG104689A BG104689A BG104689A BG10468900A BG104689A BG 104689 A BG104689 A BG 104689A BG 104689 A BG104689 A BG 104689A BG 10468900 A BG10468900 A BG 10468900A BG 104689 A BG104689 A BG 104689A
- Authority
- BG
- Bulgaria
- Prior art keywords
- central nervous
- oestrogen
- transcription
- nervous system
- estradiol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19807264 | 1998-02-20 | ||
| DE1998121831 DE19821831A1 (de) | 1998-05-15 | 1998-05-15 | Pharmazeutische Präparate zur gezielten Substitution des Estrogenmangels im Zentralnervensystem |
| PCT/DE1999/000353 WO1999042108A1 (fr) | 1998-02-20 | 1999-02-10 | Preparations pharmaceutiques pour pallier de façon ciblee la carence en oestrogenes du systeme nerveux central |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG104689A true BG104689A (en) | 2001-04-30 |
Family
ID=26044035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG104689A BG104689A (en) | 1998-02-20 | 2000-08-15 | Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1056460B1 (fr) |
| JP (1) | JP2002503694A (fr) |
| KR (1) | KR20010041107A (fr) |
| CN (1) | CN1291102A (fr) |
| AT (1) | ATE252388T1 (fr) |
| AU (1) | AU739071C (fr) |
| BG (1) | BG104689A (fr) |
| BR (1) | BR9909205A (fr) |
| CA (1) | CA2321498A1 (fr) |
| CZ (1) | CZ291764B6 (fr) |
| DE (1) | DE59907446D1 (fr) |
| EA (1) | EA002707B1 (fr) |
| EE (1) | EE03906B1 (fr) |
| HU (1) | HUP0100742A3 (fr) |
| ID (1) | ID27069A (fr) |
| IL (1) | IL137727A0 (fr) |
| IS (1) | IS5571A (fr) |
| NO (1) | NO20004153L (fr) |
| NZ (1) | NZ506049A (fr) |
| PL (1) | PL342313A1 (fr) |
| SK (1) | SK12152000A3 (fr) |
| TR (1) | TR200002400T2 (fr) |
| UA (1) | UA57830C2 (fr) |
| WO (1) | WO1999042108A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2253318T3 (es) | 2001-11-07 | 2006-06-01 | Schering Ag | Cribado in vitro de ligandos del receptor de estrogeno. |
| CN112189624A (zh) * | 2020-09-08 | 2021-01-08 | 山东第一医科大学(山东省医学科学院) | 一种利用受体基因沉默技术构建和鉴定女性ad模型的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4791099A (en) * | 1984-10-29 | 1988-12-13 | Chaovanee Aroonsakul | Method of treatment for central nervous system diseases such as Alzheimer's's disease |
| US4897389A (en) * | 1984-10-29 | 1990-01-30 | Chaovanee Aroonsakul | Treating central nervous system diseases |
| DE4239946C2 (de) * | 1992-11-27 | 2001-09-13 | Jenapharm Gmbh | Estranderivate mit einer 14alpha,15alpha-Methylengruppe und Verfahren zu ihrer Herstellung |
| US5554601A (en) * | 1993-11-05 | 1996-09-10 | University Of Florida | Methods for neuroprotection |
| DE4338314C1 (de) * | 1993-11-10 | 1995-03-30 | Jenapharm Gmbh | Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen |
| DE4429397C2 (de) * | 1994-08-09 | 2003-11-20 | Jenapharm Gmbh | Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| DE19524937A1 (de) * | 1995-07-08 | 1997-01-09 | Jenapharm Gmbh | Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen und zur medikamentösen Substitution beim Mann |
| CA2227634A1 (fr) * | 1995-07-24 | 1997-02-06 | University Of Florida Research Foundation, Inc. | Utilisation de composes phenoliques polycycliques non oestrogeniques pour la fabrication d'un medicament visant a conferer une neuroprotection cellulaire |
-
1999
- 1999-02-10 EP EP99910118A patent/EP1056460B1/fr not_active Expired - Lifetime
- 1999-02-10 EE EEP200000477A patent/EE03906B1/xx not_active IP Right Cessation
- 1999-02-10 CZ CZ20002938A patent/CZ291764B6/cs not_active IP Right Cessation
- 1999-02-10 CA CA002321498A patent/CA2321498A1/fr not_active Abandoned
- 1999-02-10 SK SK1215-2000A patent/SK12152000A3/sk unknown
- 1999-02-10 CN CN99803170A patent/CN1291102A/zh active Pending
- 1999-02-10 JP JP2000532123A patent/JP2002503694A/ja not_active Abandoned
- 1999-02-10 TR TR2000/02400T patent/TR200002400T2/xx unknown
- 1999-02-10 DE DE59907446T patent/DE59907446D1/de not_active Expired - Fee Related
- 1999-02-10 KR KR1020007009148A patent/KR20010041107A/ko not_active Application Discontinuation
- 1999-02-10 BR BR9909205-0A patent/BR9909205A/pt not_active IP Right Cessation
- 1999-02-10 NZ NZ506049A patent/NZ506049A/xx unknown
- 1999-02-10 PL PL99342313A patent/PL342313A1/xx unknown
- 1999-02-10 EA EA200000858A patent/EA002707B1/ru not_active IP Right Cessation
- 1999-02-10 AT AT99910118T patent/ATE252388T1/de not_active IP Right Cessation
- 1999-02-10 HU HU0100742A patent/HUP0100742A3/hu unknown
- 1999-02-10 IL IL13772799A patent/IL137727A0/xx unknown
- 1999-02-10 AU AU29209/99A patent/AU739071C/en not_active Ceased
- 1999-02-10 ID IDW20001592A patent/ID27069A/id unknown
- 1999-02-10 WO PCT/DE1999/000353 patent/WO1999042108A1/fr not_active Application Discontinuation
- 1999-10-02 UA UA2000095399A patent/UA57830C2/uk unknown
-
2000
- 2000-07-24 IS IS5571A patent/IS5571A/is unknown
- 2000-08-15 BG BG104689A patent/BG104689A/xx unknown
- 2000-08-18 NO NO20004153A patent/NO20004153L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SK12152000A3 (sk) | 2001-02-12 |
| HUP0100742A2 (hu) | 2001-09-28 |
| EE03906B1 (et) | 2002-12-16 |
| NO20004153D0 (no) | 2000-08-18 |
| IS5571A (is) | 2000-07-24 |
| EA200000858A1 (ru) | 2001-04-23 |
| BR9909205A (pt) | 2000-11-14 |
| CZ291764B6 (cs) | 2003-05-14 |
| UA57830C2 (uk) | 2003-07-15 |
| WO1999042108A1 (fr) | 1999-08-26 |
| EA002707B1 (ru) | 2002-08-29 |
| DE59907446D1 (de) | 2003-11-27 |
| HUP0100742A3 (en) | 2002-07-29 |
| NZ506049A (en) | 2002-09-27 |
| EP1056460B1 (fr) | 2003-10-22 |
| TR200002400T2 (tr) | 2000-11-21 |
| AU739071B2 (en) | 2001-10-04 |
| ATE252388T1 (de) | 2003-11-15 |
| CN1291102A (zh) | 2001-04-11 |
| ID27069A (id) | 2001-02-22 |
| NO20004153L (no) | 2000-10-09 |
| EP1056460A1 (fr) | 2000-12-06 |
| CZ20002938A3 (cs) | 2001-01-17 |
| JP2002503694A (ja) | 2002-02-05 |
| AU2920999A (en) | 1999-09-06 |
| PL342313A1 (en) | 2001-06-04 |
| CA2321498A1 (fr) | 1999-08-26 |
| IL137727A0 (en) | 2001-10-31 |
| KR20010041107A (ko) | 2001-05-15 |
| AU739071C (en) | 2002-04-11 |
| EE200000477A (et) | 2001-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1998027929A3 (fr) | Progestatif therapeutique pour le traitement de troubles dysphoriques premenstruels | |
| WO1996019568A3 (fr) | Analogues de ribozymes stabilises | |
| HUP0102483A2 (hu) | Androszt-5-én-3béta, 17béta-diolt tartalmazó gyógyszerkészítmények | |
| MX9700223A (es) | Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida. | |
| FR2727117B1 (fr) | ||
| PL323046A1 (en) | Procedures related to arterio-vascular and vascular transplants: method and compositions | |
| CA2337991A1 (fr) | Benzocycloheptenes, procede de production de ces composes preparations pharmaceutiques contenant ces composes et utilisation de ces composes pour la preparation de medicaments | |
| DE59510626D1 (de) | Verwendung von kompetitiven progesteronantagonisten für die herstellung von arzneimitteln zur behandlung von dysfunktionellen uterinen blutungen | |
| NZ271363A (en) | Use of antiglucocorticoid steroids to treat anxiety disorders | |
| MY137435A (en) | Retinoid compounds (i) | |
| ATE381533T1 (de) | Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung | |
| NZ333232A (en) | Use of p-aminophenol derivatives (paracetamol) to treat neurodegenerative disease | |
| BG102660A (en) | Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders | |
| BG104689A (en) | Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system | |
| MX9800049A (es) | Antraquinonas mono- y disulfo-substituidas y su uso para el tratamiento de trastornos de la matriz del hueso. | |
| ES2110258T3 (es) | Derivados de 1,3,5(10)-estratrieno activos por via oral. | |
| WO1994024279A3 (fr) | Agents pour la prevention et le traitement de la choree de huntington et d'autres troubles neurologiques | |
| ATE215556T1 (de) | 11beta-arylsubstituierte 14,17-ethano estratriene,verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln | |
| CA2421302A1 (fr) | Steroides de 17-methylene, procede permettant de les produire et compositions pharmaceutiques contenant ces composes | |
| ATE212352T1 (de) | Ungesättigte 14,15-cyclopropano-androstane, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische präparate | |
| HUP0103992A2 (hu) | Pregnán-glükuronidok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| Romanenkova | Regional demographic policy: goals, principles, possible solutions | |
| MX9800697A (es) | Uso de glicosidos de calendula para el tratamiento de psoriasis. |